China Universal Asset Management Company’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$98.6K Sell
8,228
-755
-8% -$6.27K 0.01% 416
2026
Q1
$75.3K Buy
8,983
+734
+9% +$7.71K 0.01% 430
2025
Q4
$119K Sell
8,249
-605
-7% -$7.54K 0.01% 398
2025
Q3
$85.4K Sell
8,854
-1,221
-12% -$10.8K 0.01% 402
2025
Q2
$82.7K Buy
10,075
+137
+1% +$1.15K 0.01% 380
2025
Q1
$71.1K Sell
9,938
-567
-5% -$4.22K 0.01% 388
2024
Q4
$81.2K Buy
10,505
+999
+11% +$9.38K 0.01% 416
2024
Q3
$99.7K Buy
9,506
+3,720
+64% +$45.3K 0.01% 356
2024
Q2
$67.7K Sell
5,786
-2,733
-32% -$42.5K 0.01% 333
2024
Q1
$179K Buy
8,519
+3,426
+67% +$61K 0.02% 302
2023
Q4
$91.4K Buy
5,093
+3,968
+353% +$69.9K 0.02% 294
2023
Q3
$18.5K Buy
1,125
+555
+97% +$10.1K 0.01% 302
2023
Q2
$11.4K Sell
570
-19
-3% -$366 ﹤0.01% 310
2023
Q1
$11.1K Buy
589
+150
+34% +$3.32K ﹤0.01% 283
2022
Q4
$9.96K Buy
439
+34
+8% +$769 ﹤0.01% 228
2022
Q3
$11K Buy
+405
New +$12K ﹤0.01% 198

Other funds holding RGNX

China Universal Asset Management Company's RGNX Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Regenxbio (RGNX) stake by 8.4% in Q2 2026, selling an estimated $6.27K and leaving 8,228 shares worth $98.6K. The position accounts for 0.01% of the portfolio, ranked #416.

China Universal Asset Management Company first reported a position in RGNX in Q3 2022 and has held it in 16 quarters since. The position peaked at $179K in Q1 2024. 80 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • China Universal Asset Management Company held 8,228 shares of Regenxbio worth $98.6K as of Q2 2026.
  • China Universal Asset Management Company sold 755 Regenxbio shares in Q2 2026, an estimated $6.27K.
  • Regenxbio made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #416 holding.
  • China Universal Asset Management Company first reported a position in Regenxbio in Q3 2022 and has held it in 16 quarters since.
  • China Universal Asset Management Company's Regenxbio position peaked at $179K in Q1 2024.
  • 80 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.